UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000020995
Receipt number R000024237
Scientific Title Effects of antioxidants supplementation on the quality of life
Date of disclosure of the study information 2017/12/19
Last modified on 2018/07/13 15:56:39

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of antioxidants supplementation on the quality of life

Acronym

Effects of antioxidants supplementation on the quality of life

Scientific Title

Effects of antioxidants supplementation on the quality of life

Scientific Title:Acronym

Effects of antioxidants supplementation on the quality of life

Region

Japan


Condition

Condition

Healthy subjects

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the effects about 8 weeks antioxidants supplementation on the quality of life by a randomized, double-blind, placebo-controlled study.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The 'Vitality' scores in the questionnaire of health related QOL.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Period:8 weeks
Supplementation:Antioxidants

Interventions/Control_2

Period:8 weeks
Supplementation:Placebo

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit

69 years-old >=

Gender

Male and Female

Key inclusion criteria

1.Healthy Japanese subjects aged from 40 to 69 years old
2.Subjects who are office workers.
3.Subjects who feel tired or low in vitality.
4.Subjects who have the 'Vitality' scores lower than 62.8(the national standard value) in SF-36 v2 (the questionnaire of the health related QOL) .

Key exclusion criteria

1.Subjects who have the history of diabetes, liver disease, kidney disease, heart disease, respiratory disease, chronic fatigue syndrome, or other severe diseases
2.Subjects who have had the surgery of the digestive tract.
3.Subjects who have the disease under treatment.
4.Subjects who have food or chemical allergies.
5.Smoker.
6.Subjects who regularly use health food, supplements, medicines (for example, statins, anti-hypertensive agents, hypoglycemic agents, or warfarine) or have used them within 1 month.
7.Subjects who drink excessive alcohol, or who can not stop drinking alcohol for the test day and the day before the test day.
8.Subjects who have been suffering from anemia.
9.Subjects who plays heavyexercise or who are on a diet restriction.
10.Subjects who is pregnant or breastfeeding
11.Subjects who take part in another clinical study during the study.
12.Subjects whose BMI are less than 18.5 or over 25.0.
13.Subjects whose clinical test value, blood pressure, pulse rate are markedly over or below the standard value.
14.Subjects deemed unsuitable by the investigator for other reasons

Target sample size

76


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Naoki Miura

Organization

Medical Corporation Kanonkai Miura Clinic

Division name

Internal Medicine

Zip code


Address

1-7-17, Higashitenma, Kita-ku, Osaka, Osaka

TEL

06-6135-5200

Email

tterashima@miula.co.jp


Public contact

Name of contact person

1st name
Middle name
Last name Makoto Terashima

Organization

Oneness support Co., Ltd.

Division name

Clinical trial Division

Zip code


Address

1-7-17, Higashitenma, Kita-ku, Osaka, Osaka

TEL

06-4801-8917

Homepage URL


Email

shiken@oneness-sup.co.jp


Sponsor or person

Institute

Oneness support Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

KYOWA HAKKO BIO CO., LTD

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 12 Month 19 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 12 Month 28 Day

Date of IRB


Anticipated trial start date

2016 Year 02 Month 15 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 02 Month 12 Day

Last modified on

2018 Year 07 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024237


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name